By univariate analyses, BAX (BSI), Bcl-2 and p53 immunostainings were compared with treatment arm and various tumour characteristics (sex, age, pT category, pN category, grade of differentiation (G category) or localisation). This evidence concerns the gene BAX and neoplasm.